市场调查报告书
商品编码
1578764
越南人用疫苗进口量:2024-2033年Vietnam Human Vaccines Import Research Report 2024-2033 |
人类疫苗多年来一直具有保护作用,在人类健康中发挥重要作用。在现代生活中,疫苗接种已成为预防某些疾病特别是流行病和传染病的最有效方法,并广泛接受。
到2023年底,越南总人口将突破1亿,净人口每年增加超过100万人。随着经济发展和资本收入增加,越南製药业成长强劲。此外,越南政府持续实施扶持政策,扩大医疗支出。根据CRI报道,越南自由贸易协定消除了外国製药企业的市场准入壁垒,对来自欧洲和部分地区的药品进口关税非常低,甚至没有。越南製药业高度依赖进口药品。
疫苗可以预防某些疾病、减少疾病传播并改善公众健康。 CRI分析表示,越南对人用疫苗的需求稳步成长。但由于国内产能有限,越南人用疫苗市场主要依赖进口产品。近年来,越南进口了大量疫苗,包括COVID-19疫苗、流感疫苗、HPV疫苗以及四价和六价儿科疫苗。越南对疫苗的需求很高,进口人用疫苗的数量不断增加,特别是在COVID-19之后,因为政府和人民都更加重视健康。
疫苗产业有原料供应(抗原、佐剂等)及製造业(研究、製造、品质管制等)等上游环节,以及经销及免疫服务等下游环节。疫苗生产需要严格的卫生条件、先进的製造设备和技术以及高标准的品质控制。全球主要疫苗生产和出口企业都是研发能力较强的大型生物製药公司,如Pfizer、Moderna、AstraZeneca等,而目前越南国内企业只能生产有限种类的疫苗。
在 COVID-19 期间,越南进口了大量疫苗以满足紧急需求。根据CRI表示,越南人用疫苗生产的基础设施和技术落后,使其高度依赖国际市场供应。此外,越南政府高度重视公共卫生,并透过涵盖常见传染病的国家免疫计划(NIP)促进提高疫苗接种覆盖率。越南已与多家国际疫苗供应商签署合作协议,确保疫苗稳定供应。
根据CRI资料,2023年越南人用疫苗进口总额达4.7亿美元。此外,2024年1月至5月,越南疫苗进口总额超过2.5亿美元,比上年增加30%以上。预计这一趋势在未来几年将继续以稳定的速度成长。
整体而言,由于越南人口成长、经济水准提高以及健康意识的提高,越南人用疫苗市场规模预计将扩大。根据CRI分析,由于越南国产人用疫苗产能和技术水准相对较低,未来几年越南人用疫苗进口预计将持续成长。
本报告调查了越南人用疫苗进口趋势,包括国家概况、进口额、进口量、进口价格等趋势和预测,主要进口国和主要买家的详细分析,并进行了总结木製家具出口供应商及主要影响因素分析
免责声明
服务保障
Human vaccines offer longstanding protection, playing an indispensable role in human health. In modern life, vaccination has become the most effective way to prevent from specific diseases, especially pestilences and infection, widely accepted by people.
By the end of 2023, Vietnam's total population has surpassed 100 million, with a net population growth of more than 1 million annually. As the economy progressing and capital income increasing, the pharmaceutical industry in Vietnam is growing vigorously. Also, the Vietnam government continues to issue support policies and expand healthcare spending. For example, the national strategy for pharmaceutical industry development through 2030, with a vision to 2045 approved in 2023 set out clear development targets for specific industry including vaccines. According to CRI, Vietnam's free trade agreements have removed market access barriers for foreign companies in its pharmaceutical industry, and import tariffs on medicines from Europe and some regions are very low or even non-existent. Vietnam's pharmaceutical industry is highly dependent on imported pharmaceutical products.
Vaccines can prevent certain diseases, reduce the spread of illness, and improve public health. CRI has analyzed that the demand for human vaccines in Vietnam is steadily increasing. However, due to limited domestic production capacity, Vietnam's human vaccine market mainly relies on imported products. In recent years, Vietnam has imported a large number of vaccines, including COVID-19 vaccines, influenza vaccines, HPV vaccines, and quadrivalent and hexavalent pediatric vaccines. The demand for vaccines in Vietnam is high, especially in the post-COVID-19 era, as both the government and the public place greater emphasis on health, leading to an increase in the number of imported human vaccines.
The vaccine industry involves upstream sectors such as raw material supply (e.g., antigens, adjuvants), manufacturing (including research, production, and quality control), and downstream sectors like distribution and vaccination services. Vaccine production requires strict hygiene conditions, advanced production equipment and technology, and high standards of quality control. Leading global vaccine producers and exporters are typically large biopharmaceutical companies with strong R&D capabilities, such as Pfizer, Moderna, and AstraZeneca. Currently, Vietnamese domestic companies are only able to produce a limited variety of vaccines.
During the COVID-19 pandemic, Vietnam imported a significant number of vaccines to meet the urgent demand. According to CRI, because of the underdeveloped infrastructure and technology for human vaccine production in Vietnam, the country is heavily reliant on the international market for supply. Moreover, the Vietnamese government is highly committed to public health, promoting higher vaccination rates through the National Immunization Program (NIP), which covers a range of common infectious diseases. Vietnam has entered into cooperation agreements with various international vaccine suppliers to ensure a stable supply of vaccines.
Based on data from CRI, in 2023, Vietnam's total imports of human vaccines reached USD 470 million. From January to May 2024, Vietnam's total vaccine imports exceeded USD 250 million, representing a year-on-year growth of over 30%. This trend is expected to continue at a steady growth rate in the coming years.
CRI's analysis reveals that from 2021 to 2024, Vietnam's primary sources of human vaccine imports were the United States, France, and Belgium. Major companies exporting human vaccines to Vietnam include GlaxoSmithKline Biologicals S.A., Merck Sharp & Dohme (Asia) Ltd., and Sanofi Pasteur.
The main importers of human vaccines in Vietnam are pharmaceutical companies, distributors, and logistics providers, mostly foreign enterprises, such as GSK Pharma Vietnam Company, MSD HH Vietnam Ltd., and Sanofi-Aventis Vietnam Company.
Overall, with Vietnam's growing population and rising economic level, coupled with increased awareness of health, the size of Vietnam's human vaccine market is set to expand. CRI's analysis indicates that due to the relatively low production capacity and technological levels of domestic human vaccines, Vietnam's human vaccine imports are expected to continue growing in the coming years.
Topics covered:
The Import and Export of Human Vaccines in Vietnam (2021-2024)
Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2021-2024)
Total Import Value and Percentage Change of Human Vaccines in Vietnam (2021-2024)
Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2024)
Total Import Value and Percentage Change of Human Vaccines in Vietnam (2024)
Average Import Price of Human Vaccines in Vietnam (2021-2024)
Top 10 Sources of Human Vaccines Imports in Vietnam and Their Supply Volume
Top 10 Suppliers in the Import Market of Human Vaccines in Vietnam and Their Supply Volume
Top 10 Importers of Human Vaccines in Vietnam and Their Import Volume
How to Find Distributors and End Users of Human Vaccines in Vietnam
How Foreign Enterprises Enter the Human Vaccines Market of Vietnam
Forecast for the Import of Human Vaccines in Vietnam (2024-2033)
Disclaimer
Service Guarantees